Mortality and non-alcoholic fatty liver disease: type of study cohort matters!
Madan, K.; Dhingra, A.
National Medical Journal of India 25(1): 28-30
2012
ISSN/ISBN: 0970-258X PMID: 22680320 Document Number: 658848
Document emailed within 1 workday
Related Documents
Yoshihara, H.; Sato, N.; Kubota, S.; Inoue, A.; Matsumura, T.; Hayashi, N.; Kawano, S.; Kamada, T. 1985: Serum holo and apo type activity of mitochondrial GOT in patients with alcoholic liver disease--with special reference to alcoholic fatty liver Arukoru Kenkyu to Yakubutsu Izon 20(2): 166-174Zhu, Q.-q.; Lou, D.-j.; Si, X.-w.; Guan, L.-l.; You, Q.-y.; Yu, Z.-m.; Zhang, A.-z.; Li, D. 2010: Serum omega-3 polyunsaturated fatty acid and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease Zhonghua Nei Ke Za Zhi 49(4): 305-308
Liu, Y.; Hong, T. 2015: The pathogenesis and management of non-alcoholic fatty liver disease coexisted with type 2 diabetes Zhonghua Yi Xue Za Zhi 95(44): 3565-3567
Shukla, V.; Fatima, J.; Chaudhary, S.; Ali, M.; Mishra, I. 2017: A Study of Endothelial Dysfunction in Patients of Non-Alcoholic Fatty Liver Disease Journal of the Association of Physicians of India 65(9): 18-22
Ishii, K.-a.; Takamura, T. 2016: Non-alcoholic fatty liver disease (NAFLD) /non-alcoholic steatohepatitis (NASH) and nutrition Clinical Calcium 26(3): 363-367
Niriella, M.A.; Pathmeswaran, A.; De Silva, S.T.; Kasturiratna, A.; Perera, R.; Subasinghe, C.E.; Kodisinghe, K.; Piyaratna, C.; Rishikesawan, V.; Dassanayaka, A.S.; De Silva, A.P.; Wickramasinghe, R.; Takeuchi, F.; Kato, N.; de Silva, H.J. 2017: Incidence and risk factors for non-alcoholic fatty liver disease: a 7-year follow-up study among urban, adult Sri Lankans Liver International: Official Journal of the International Association for the Study of the Liver 37(11): 1715-1722
Aller, R.; De Luis, D.A.; Fernandez, L.; Calle, F.; Velayos, B.; Izaola, O.; Gonzalez Sagrado, M.; Conde, R.; Gonzalez, J.M. 2009: Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on histological alterations and insulin resistance of non alcoholic fatty liver disease European Review for Medical and Pharmacological Sciences 13(5): 357-364
Jin, H-Bin.; Gu, Z-Ying.; Yu, C-Hui.; Li, Y-Ming. 2005: Association of nonalcoholic fatty liver disease with type 2 diabetes: clinical features and independent risk factors in diabetic fatty liver patients Hepatobiliary and Pancreatic Diseases International: Hbpd Int 4(3): 389-392
Karim, M.R.; Ahmed, H.; Paul, R.K.; Chowdhury, M.; Alam, M.S.; Saha, A. 2016: Comparative Study between Pentoxifylline and Pioglitazone in the Treatment of Non-Alcoholic Fatty Liver Disease among Newly Detected Glucose Intolerant Patients Mymensingh Medical Journal: Mmj 25(2): 198-204
Yatsuji, S.; Hashimoto, E. 2006: Natural history of Japanese patients with non-alcoholic fatty liver disease (NAFLD), especially non-alcoholic steatohepatitis (NASH) patients with hepatocellular carcinoma (HCC) Nihon Rinsho. Japanese Journal of Clinical Medicine 64(6): 1173-1179
Bannister, P.; Oakes, J.; Sheridan, P.; Losowsky, M.S. 1987: Sex hormone changes in chronic liver disease: a matched study of alcoholic versus non-alcoholic liver disease Quarterly Journal of Medicine 63(240): 305-313
Joos, W.; Mörl, M. 1984: Alcohol-induced organic lesions. 3. Liver damage - alcoholic fatty liver, alcoholic hepatitis, acute and chronic clinical course Fortschritte der Medizin 102(4): 79-82
Dasarathy, J.; Allampati, S.; Alexander, C.; McCullough, A. 2016: Non-alcoholic fatty liver disease: What's in our arsenal? Journal of Family Practice 65(4): 239-244
Sdiri, W.; Romdhane, H.; Mbarek, D.; Ben Abdallah, H.; Longo, S.; Abdelli, M.N.; Boujnah, M.R. 2013: Non alcoholic fatty liver disease: a new risk factor for cardiovascular disease? La Tunisie Medicale 91(3): 171-174
Björklund, J.; Laursen, T.L.; Kazankov, K.; Thomsen, K.L.; Hamilton-Dutoit, S.; Stenbøg, E.; Grønbæk, H. 2017: Non-alcoholic fatty liver disease in children and adolescents Ugeskrift for Laeger 179(27)
Fan, J.-G.; Farrell, G.C. 2009: Epidemiology of non-alcoholic fatty liver disease in China Journal of Hepatology 50(1): 204-210
Abenavoli, L.; Milic, N.; Luigiano, C. 2014: Low 25-hydroxyvitamin D3 serum levels and non-alcoholic fatty liver disease Minerva Medica 105(2): 175
Roĭtberg, G.E.; Sharkhun, O.O.; Ushakova, T.I. 2010: Non-alcoholic fatty liver disease as an atherosclerosis risk factor Eksperimental'naia i Klinicheskaia Gastroenterologiia 7: 20-24
Heebøll, S.; Kazankov, K.; Poulsen, M.K.ær.; Vilstrup, H.; Grønbæk, H. 2012: Prognosis and treatment of non-alcoholic fatty liver disease and steatohepatitis Ugeskrift for Laeger 174(8): 488-490
Hurjui, D.M.; Niţă, O.; Graur, L.I.; Mihalache, L.; Popescu, D.S.; Graur, M. 2012: The central role of the non alcoholic fatty liver disease in metabolic syndrome Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 116(2): 425-431